HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hugh Walton Selected Research

Neoplasms (Cancer)

1/2021Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hugh Walton Research Topics

Disease

1COVID-19
08/2022
1Infections
08/2022
1Neoplasms (Cancer)
01/2021
1Melanoma (Melanoma, Malignant)
01/2018

Drug/Important Bio-Agent (IBA)

1Ritonavir (Norvir)FDA Link
08/2022
1nirmatrelvirIBA
08/2022
1nirmatrelvir and ritonavir drug combinationIBA
08/2022
1ASTX029IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
01/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018